Target Product Profile for Monoclonal Antibodies for West Nile Virus Disease Prevention: Request for Information

Official abstract: The Centers for Disease Control and Prevention (CDC) in the Department of Health and Human Services (HHS) announces the opening of a docket to obtain comment on the proposed Target Product Profile for Monoclonal Antibodies for West Nile Virus Disease Prevention. This Request for Information (RFI) invites comments and suggestions on the proposed target product profile. The objective of the target product profile is to describe key minimal and optimal attributes for a West Nile virus monoclonal antibody product that can be provided to patients at higher risk for severe West Nile virus disease as pre- or post- exposure prophylaxis. This input is a valuable component in developing a useful target product profile.